From professional translators, enterprises, web pages and freely available translation repositories.
concept paper on the development of a cpmp note for guidance on the clinical investigation of medicinal products in pain management adoptada en junio de 2000
concept paper on the development of a cpmp note for guidance on the clinical investigation of medicinal products in the treatment of asthma adopted february 2000
la gran mayoría de los pacientes que acuden al bergen pain management® center, si responden a la terapia de inyecciones sin necesitar otros tratamientos.
however there are patients who do not respond adequately to injection therapy.
buprenorphine, a partial agonist of the μ-opioid receptor, binds with weak morphine-like activity and is used clinically as an analgesic in pain management and as an alternative to methadone in the treatment of opioid dependence.
buprenorphine, a partial agonist of the μ-opioid receptor, binds with weak morphine-like activity and is used clinically as an analgesic in pain management and as an alternative to methadone in the treatment of opioid dependence.
"es un artículo que podría ser muy importante", dice el dr. edgar l. ross, director del pain management center en bringham y del women's hospital en boston, y profesor asociado de la facultad de medicina de harvard university. ross, que trabaja con un acupunturista en su centro, explica que ve beneficios similares, aunque el promedio del 50% en la reducción del dolor reportado en el estudio fue mayor que el que experimentaron sus pacientes.
"it's a potentially very important article," says edgar l. ross, m.d., director of the pain management center at brigham and women's hospital in boston and an associate professor at harvard medical school. ross, who works with an acupuncturist at his center, says he sees similar benefits, although the average 50 percent pain reduction reported in the study was greater than that experienced by his patients.
